[Correlation of <i>BRAF V600E</i> Mutation with Clinical Features and Prognosis of Langerhans Cell Histiocytosis in Cildren].
LCH is an inflammatory myeloid tumor. <i>BRAF V600E</i> mutation is not correlated with clinical features, early treatment response, recurrence and prognosis of LCH.
Authors
- Jie Yu (ORCID: https://orcid.org/0000-0002-9912-2627)
- Xinyuan Yao
- Xiao Li (ORCID: https://orcid.org/0000-0002-6630-0503)
- Haiyan Liu (ORCID: https://orcid.org/0009-0002-1452-6743)
- Xi Li (ORCID: https://orcid.org/0009-0008-4480-8251)
- Yuxia Guo (ORCID: https://orcid.org/0000-0003-0014-6862)
- Ying Dou
- Xiaoying Lei
- Mingzhu Luo
Institutions
- China International Science and Technology Cooperation (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.043
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article